🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Management Concepts of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Among Chinese Physicians

Recruitingn/aAges 18 Years - anyAllNovo Nordisk A/S
NCT07682363 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study is a cross-sectional survey-based study. The main goal of this study is to investigate the attitudes, perceptions, and clinical practice in assessing liver fibrosis following a metabolic dysfunction-associated steatotic liver disease (MASLD) diagnosis, and the management of MASLD patients among Chinese physicians in the departments of endocrinology / hepatology / infection / gastroenterology in Grade IIIA hospitals in provincial capitals or municipalities.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Has provided informed consent. * Registered clinical practice location in provincial capital or municipality. * Physician with a license for clinical practice. * Employed in the Department of Endocrinology, Hepatology, Infection or Gastroenterology. * Hospital level: Grade IIIA hospital. * Hold a professional title of associate chief physician or above, or senior attending physician (as an attending physician for more than or equal to (≥) 3 years). * Conducts outpatient clinics for at least 1 half-days per week. * The patient load of MASLD/MASH per month in the department should be: * a. Endocrinology ≥20 patients per month * b. Hepatology/Gastroenterology/ Infectious ≥30 patients per month Exclusion Criteria: -Participants will be excluded if they have unwillingness precluding adequate cooperation, fail to complete the questionnaire, or submit questionnaires verified as invalid.
💊

What it tests

  • No treatment is given
📍

Where

1 site
Novo Nordisk Investigational site
Beijing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy